Home / Products / Cancer (Tumor) Cell Lines / YD-38
YD-38
Datasheet Protocol

YD-38

Cat. No. ARC1023
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Oral cavity (gingiva)

Growth Properties:

Adherent

In stock
Request a Quote
Request Quote Ask a Question

Short Description 🔒

YD-38 is a cancer cell line of oral cavity (gingiva) squamous cell carcinoma, isolated from in situ; oral cavity.

Recommended Products

MOGAT2 Knockout NCI-H1299 Polyclonal Cells MOGAT2 Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG17691 P4HB Knockout HT29 Polyclonal Cells P4HB Knockout HT29 Polyclonal Cells Cat. No. ARG13948 ANKRD17 Knockout HAP1 Polyclonal Cells ANKRD17 Knockout HAP1 Polyclonal Cells Cat. No. ARG27260 HACL1 Knockout A549 Polyclonal Cells HACL1 Knockout A549 Polyclonal Cells Cat. No. ARG33620 DNAJB14 Knockout jurkat Polyclonal Cells DNAJB14 Knockout jurkat Polyclonal Cells Cat. No. ARG39111 NANS Knockout 786-O Polyclonal Cells NANS Knockout 786-O Polyclonal Cells Cat. No. ARG5594
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Oral cavity (gingiva)
Disease:
Squamous cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
67 years
Derived From Site:
In situ; Oral cavity
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

FMR1 Knockout 143B Polyclonal Cells

FMR1 Knockout 143B Polyclonal Cells

Cat. No. ARG11903
 GOLM1 Knockout HGC-27 Polyclonal Cells

GOLM1 Knockout HGC-27 Polyclonal Cells

Cat. No. ARG29835
 IRGQ Knockout SKOV3 Polyclonal Cells

IRGQ Knockout SKOV3 Polyclonal Cells

Cat. No. ARG36747
 DNAJC13 Knockout NCI-H1299 Polyclonal Cells

DNAJC13 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG39203
 GPRIN1 Knockout AGS Polyclonal Cells

GPRIN1 Knockout AGS Polyclonal Cells

Cat. No. ARG26876
 CDKN1A Knockout Raji Polyclonal Cells

CDKN1A Knockout Raji Polyclonal Cells

Cat. No. ARG1586